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Abstract
Hydrogen sulfide (H2S) is a novel gasotransmitter that inhibits L-type calcium currents (I Ca, L). However, the underlying
molecular mechanisms are unclear. In particular, the targeting site in the L-type calcium channel where H2S functions
remains unknown. The study was designed to investigate if the sulfhydryl group could be the possible targeting site in the
L-type calcium channel in rat cardiomyocytes. Cardiac function was measured in isolated perfused rat hearts. The L-type
calcium currents were recorded by using a whole cell voltage clamp technique on the isolated cardiomyocytes. The L-type
calcium channel containing free sulfhydryl groups in H9C2 cells were measured by using Western blot. The results showed
that sodium hydrosulfide (NaHS, an H2S donor) produced a negative inotropic effect on cardiac function, which could be
partly inhibited by the oxidant sulfhydryl modifier diamide (DM). H2S donor inhibited the peak amplitude of I Ca, L in a
concentration-dependent manner. However, dithiothreitol (DTT), a reducing sulfhydryl modifier markedly reversed the H2S
donor-induced inhibition of I Ca, L in cardiomyocytes. In contrast, in the presence of DM, H2S donor could not alter cardiac
function and L type calcium currents. After the isolated rat heart or the cardiomyocytes were treated with DTT, NaHS could
markedly alter cardiac function and L-type calcium currents in cardiomyocytes. Furthermore, NaHS could decrease the
functional free sulfhydryl group in the L-type Ca
2+ channel, which could be reversed by thiol reductant, either DTT or
reduced glutathione. Therefore, our results suggest that H2S might inhibit L-type calcium currents depending on the
sulfhydryl group in rat cardiomyocytes.
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Introduction
In addition to the gasotransmitters nitric oxide (NO) and carbon
monoxide (CO), hydrogen sulfide (H2S) is the third biologic signal
gaseous molecule and is recognized as an important physiologic
regulator in the circulatory, nervous, endocrine and immune
systems [1]. In the investigation of broad physiological functions,
the cardio-protective effect of H2S was first found and drew much
attention in the field of life sciences. H2S can be endogenously
generated from cysteine by the cystathionine-U-lyase (CSE)
enzyme in the cardiovascular system [2]. In vitro and in vivo
experiments showed that H2S induced negative cardiac inotropic
effects and played a cardio-protective role in various models of
diseases. It was also found that exogenous H2S post-conditioning
successfully protected isolated rat hearts against ischemia-reperfu-
sion injury [3] and played a protective role in chronic heart failure
[4]. However, the mechanism responsible for the negative cardiac
inotropic effects of H2S has not been fully understood.
L-type calcium channels are decisive in the excitation/
contraction coupling in cardiomyocytes, and they provide the
main pathway through which Ca
2+ enters into myocardial cells;
therefore, the Ca
2+ entering through these channels may trigger
the Ca
2+-induced Ca
2+ release. The amount of Ca
2+ released from
intracellular calcium stores and the Ca
2+ entering the sarcoplasmic
reticulum (SR) from outside the cells maintain intracellular
calcium homeostasis, which plays a fundamental role in myocar-
dial physiology and pathology [5]. In 2008, Sun, et al.
demonstrated that H2S could inhibit L-type calcium channels in
cardiomyocytes [6]. However, the potential targeting site on L-
type calcium channels has not been clarified.
H2S is more potently toxic than cyanide since it blocks
cytochrome C oxidase that results in mitochondrial respiration
inhibition [7,8]. The transformation of disulfide bridges into
sulfhydryl groups of the cysteine-containing proteins at the center
of cytochrome C oxidase was regarded as the mechanism for
intoxication of H2S [9]. Toxicological experiments showed that
pre-treatment with oxidized glutathione (GSSG) or methemoglo-
binemia could protect experimental mammals against a subse-
quent lethal challenge from inorganic sulfide poisoning; alterna-
tively, a method of de-intoxication of H2S involves trapping free
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[9]. Thus, the disulfide bridges or the sulfhydryl groups of the
cysteine-containing proteins may be the effective targets of H2S.
Meanwhile, the subunits of the L-type calcium channel [10] and
ATP sensitive potassium channel [11] were found to contain
functionally important free sulfhydryl groups that modulate gating.
Therefore, we hypothesized that a novel mechanism of activation
of the channels might resulted from the formation of a disulfide
bridge between cysteine residues of the pore and that H2S might
have an accommodating gate on the channels mentioned above
with ‘‘Cys-SH’’ as the critical target.
The protein structure and function of thiol-containing com-
pounds, containing cysteine residues which can form a disulfide
bond when the sulfhydryl group of cysteine is oxidized, could be
altered. Sulfhydryl reagents have been widely used as a
pharmacological tool to explore the molecular functions of
channel proteins. The fact that L-type calcium channels are
subjected to direct modification by sulfhydryl reagents has been
demonstrated [12].
Therefore, the present study was undertaken to investigate
whether the inhibitory effects of L-type calcium channel induced
by H2S was dependent on the disulfide bridge or sulfhydryl group.
Methods
Ethics Statement
All animal experimental procedures conformed to the ‘‘Guide
for the Care and Use of Laboratory Animals’’ published by the
National Institutes of Health (NIH) in the United States and ‘‘The
use of non-human primates in research’’, and the Animal
Research Ethics Committee of Peking University First Hospital
specifically approved this study with the permit number of
J200913.
Animals
Male Sprague-Dawley (SD) rats with a body weight of 200–
250 g were obtained from Vital River (Beijing, China). The rats
were housed in cages and fed a standard laboratory diet and fresh
water. The cages were kept in a room with controlled temperature
(2461uC), relative humidity (65–70%) and 12 hour light/dark
cycle.
Chemicals
NaHS, collagenase I, protease E aminoethylsulfonic acid, L-
aminoglutaminic acid, CsOH, CsCl, nifedipine, (6) Bay K8644,
diamide (DM), dithiothreitol (DTT), reduced L-glutathione
(GSH), L-cysteine (L-CY), Na2ATP, and Na2GTP were purchased
from Sigma (St Louis, MO, USA). Bovine serum albumin (BSA),
HEPES and EGTA were purchased from Amresco (Solon, USA).
TTX was purchased from Aquatic Products Research Institute
(Hebei, China). NaHS was dissolved in bath solutions. Fresh stock
solutions were then diluted with bath solution to yield H2S
solutions of various concentrations.
Experimental protocol of measurement of cardiac
function in vivo
All rats were anesthetized with 12% urethane (1 ml/100 g, i.p.).
The isolated hearts were removed quickly and fixed using the
Langendorff perfusion apparatus with the left auricular appendage
removed. They were retroperfused in the aorta with the 37uC
Krebs-Henseleit (K-H) solution containing the following at mmol/
L concentrations: NaCl, 118.0; KCl, 4.7; KH2PO4, 0.93;
MgSO4?7H2O, 1.2; CaCl2, 1.5; NaHCO3, 25; C6H12O6, 11.0;
pH 7.4, mixed by 95% O2 and 5% CO2. A balloon catheter was
inserted into the left ventricle for the measurement of left
ventricular systolic pressure (LVSP) and the left ventricular (LV)
pressure (6dp/dtmax). The balloon was connected to a pressure
transducer with the computer. The fluid was adjusted to obtain a
left ventricular end-diastolic pressure (LVEDP) under 10 mmHg.
For all rats, cardiac function was assessed by using the Powerlab
(4S, Australia) after a 20 min equilibration period. Subsequent
procedures were as follows. Thirty-three rats were randomly
divided into five groups: 1) isolated rat hearts (n=6) were
equilibrated 20 min in the K-H solution, then perfused with the
K-H solution with 100 mmol/L NaHS for 10 min, and the cardiac
function was again determined by Powerlab; 2) after 20 min
stabilization, the isolated hearts (n=6) were perfused with the K-H
solution with 100 mmol/L DM for 5 min, and the cardiac function
of this stage was also recorded. Subsequently, the K-H solution
with 100 mmol/L NaHS was used to perfuse the hearts and the
data were assessed; 3) isolated rat hearts (n=6) were firstly
equilibrated 20 min in the K-H solution, and then perfused with
the K-H solution with 100 mmol/L DTT for 5 min. Finally the K-
H solution with 100 mmol/L NaHS was infused into the hearts,
and the cardiac functions were observed by Powerlab; 4) isolated
rat hearts (n=9) were perfused with the K-H solution with
nifedipine at a dosage of 10 mmol/L for 5 min, and the cardiac
function at this stage was recorded. Subsequently, hearts were
perfused with the K-H solution with 100 mmol/L NaHS, and the
data were also recorded; 5) isolated rat hearts (n=6) were perfused
with the K-H solution with nifedipine at a dosage of 10 mmol/L
for 5 min, and the cardiac function was recorded at this stage. The
hearts were subsequently perfused with the K-H solution alone
and the same indexes were recorded by Powerlab. Alteration of
left ventricular pressure [DLVP=left ventricular systolic pressure
(LVSP)-left ventricular end diastolic pressure (LVEDP)] was
calculated to reflect the maximum contractility of left ventricle
myocardium; +dp/dtmax indicates the maximum contractile
velocity of myocardium, while 2dp/dtmax represents the myocar-
dial maximum diastolic ability.
Cardiomyocyte isolation
Single cells were obtained by following a method described by
Zhang et al. with modifications [13]. Briefly, each rat was
anesthetized with 12% ethylcarbamate (1 ml/100 g i.p.). The
heart was rapidly excised and attached to an improved
Langendorf perfusion apparatus. The heart was then retrogradely
perfused for 5 min at 37uC with Ca
2+-free Tyrode’s solution
containing (in mmol/L) NaCl 137, KCl 5.4, NaH2PO4 0.33,
MgCl2 1.0, glucose 10, and HEPES 10, and the pH was adjusted
to 7.3–7.4 with NaOH after the solution was equilibrated with
95% O2 and 5% CO2. Enzymatic digestion with a steady
perfusion pressure of 80 mmol/L Hg was achieved by re-
circulating the perfusion apparatus with the low calcium
oxygenated Tyrode’s solution containing 0.8 mg/ml collagenase
Type I, protease E 0.1 mg/ml, 0.5 mg/ml BSA, and 20 mmol/L
Ca
2+ for 13–15 min. The ventricles were separated from the heart,
cut into small pieces, and stirred to obtain a cell suspension at
37uC in oxygenated KB solution containing (in mmol/L) KOH
80, KCl, 40, KH2PO4 20, glutamic acid 50, MgSO4 3, taurine 20,
EGTA 0.5, HEPES 10, and glucose 10, and the pH was adjusted
to 7.3–7.4 with KOH. After 3 min of stirring for 3 separate times,
the cell suspensions were centrifuged and washed with 1 mmol/L
CaCl2. Finally, the isolated cells were suspended in KB solution
containing 0.5 mg/ml BSA and stored at room temperature for
30 min to 1 h before experiments. Rod-shaped cells with clear
cross-striations without automatic contraction were used in the
present study.
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Currents of L-type calcium channels were recorded under
voltage clamping in the whole-cell configuration of the patch-
clamp technique. Cardiomyocytes were placed in a dish at the
stage of an inverted microscope (IX70, Olympus Inc., Tokyo,
Japan) and were continuously perfused at a constant rate (1.5 ml/
min) with a oxygenated solution containing (in mmol/L) NaCl
137, CaCl2 1.8, MgCl2 1, CsCl 5.4, TTX 0.02, 4-AP 4, HEPES
10, and glucose 10 (pH adjusted to 7.3–7.4 with NaOH). Single
cells were voltage-clamped using a patch-clamp amplifier
(Axopatch 200B, Axon Instruments, Burlingham, CA, USA).
Physiological signals was recorded by pClamp 6.0 (Axon
Instruments). Pipettes for whole-cell patch-clamp recordings were
made from borosilicate glass capillaries and had resistances of 1 to
3M V. The pipette solution contained (in mmol/L) CsCl 130,
MgCl2 1, Na2ATP 5, Na2GTP 0.5, EGTA 11, and HEPES 10
(pH adjusted to 7.3 with CsOH). The I Ca, L current was measured
under the conditions described above. K
+ currents were
suppressed by internal Cs
+ and 4-AP in the perfusion solution,
as well as by external K
+-free solution. The Na
+ current was
suppressed by TTX. The Na
+-K
+ pump current was inactivated in
K
+-free bath solutions and Na
+-free pipette solutions. Membrane
currents associated with Na
+-Ca
2+ exchange was eliminated by the
Na
+-free and low-Ca
2+ (11 mmol/L EGTA) pipette solutions.
Application of nifedipine (10 mmol/L) to the bath solution could
completely inhibit the peak I Ca, L within 1 min, confirming that
the measured current was due to I Ca, L.
I–V relationship of I Ca, L was obtained by plotting the peak
current amplitude in response to voltage pulses to potentials
between 240 and +70 mV from a holding potential of 240 mV
(steps of 10 mV increments). The steady state activation of I Ca, L
was determined by applying 200 ms of depolarizing pulses
between 270 mV and +30 mV from a holding potential of
270 mV. The steady-state inactivation of I Ca, L was determined
by applying a two-pulse protocol containing 1 s pre-pulses
between 270 and +30 mV and a subsequent 200 ms of test pulse
to 0 mV from a holding potential of 270 mV. The recovery of I
Ca, L from inactivation was tested with a double-pulse protocol
consisting of a 200 ms of conditioning pulse to 0 mV followed by a
200 ms of test pulse to 0 mV from a holding potential of 270 mV
with increasing interval steps of 20 ms between 20–500 ms. To
standardize membrane currents to Cm, the capacity current
transiently measured in response to a 5 mV hyperpolarizing pulse
was integrated and divided by the given voltage to yield total Cm
for each cell. Various concentrations of NaHS were applied by a
fast puffing system. All experiments were performed at a room
temperature of 21–23uC.
Cell culture and identification of protein containing free
sulfhydryl groups
H9C2 cells grown in 100-mm plates were incubated with
Dulbecco’s modified Eagle’s medium (DMEM, Invitrogen,
Carlsbad, CA, USA) administrated with 10% fetal bovine serum
(FBS, Invitrogen, Carlsbad, CA, USA), 2 mmol/L L-glutamine,
100 U/ml penicillin and 100 mg/ml streptomycin under 37uC,
5% CO2 and saturated humidity for cell growth. When H9C2
cells reached at 80–90% confluence, the complete medium was
changed into serum-free medium for 24 h and then incubated in
DMEM containing 10% FBS. In the NaHS group, H9C2 cells
were respectively treated with NaHS at 100 mmol/L for 30 min,
DM at 100 mmol/L for 5 min, DTT at 5 mmol/L for 5 min,
GSH at 5 mmol/L for 5 min, L-CY at 5 mmol/L for 5 min, and
NaHS at 100 mmol/L for 25 min followed by DTT at 5 mmol/L
for 5 min or followed by GSH at 5 mmol/L for 5 min. While, in
the control group H9C2 cells were just incubated with 10% FBS
DMEM for the same period. Then, H9C2 cells were solubilized in
1 ml of lysis buffer, and cell lysates were incubated with 50 mlo f
EZ-LinkTM PEO-iodoacetyl Biotin (10 mg/ml; Pierce) for 12 h at
4uC and then incubated with 30 ml of UltraLinkTM Immobilized
NeutrAvidinTM (Pierce) for 4 h on a roller system at 4uC. The
beads were washed twice with 1 ml of lysis buffer and three times
with 1 ml of PBS. For Western blot analysis, proteins containing
sulfhydryl groups of H9C2 cells were subjected to SDS-PAGE,
and the proteins were transferred to nitrocellulose membranes.
Membranes were probed with anti-L-type calcium channel
antibody (Sigma, Saint Louis, Missouri, USA) and developed
with Western blotting luminol reagents (Santa Cruz Biotechnol-
ogy, Santa Cruz, CA, USA).
Statistical analysis
The data were analyzed with the pCLAMP 10.0 (Axon
Instruments), SPSS 13.0 and Microcal Origin 6.0 software. All
data in the figures were expressed as mean 6 SD. Differences
among groups were analyzed with one-way ANOVA followed by
LSD or Dunnett’s post-hoc test where applicable. Significance was
established at the P,0.05 level.
Results
The effect of NaHS on cardiac function
With 100 mmol/L NaHS continuous perfusion at a physiolog-
ical dosage for 10 min, LV 6 dp/dtmax and DLVP decreased
significantly compared with the control (P,0.01, Fig. 1A).
Sulfhydryl modifiers impacted NaHS-induced inhibition
of cardiac function in isolated perfused rat hearts
To examine if the NaHS-induced inhibitory effect on cardiac
function in isolated perfused rat hearts depended upon the protein
sulfhydryl group, we used DM, an oxidizing sulfhydryl modifier to
transform protein sulfhydryl groups into disulfide bridges. The LV
6dp/dtmax and DLVP decreased after perfusion with DM at
dosage of 100 mmol/L for 5 min as compared with controls
(P,0.05, Fig. 1B). However, in the presence of DM perfusion
fluid, the LV 6dp/dtmax and DLVP were not altered when
continuously perfused with 100 mmol/L NaHS for 10 min
(P.0.05, Fig. 1B).
Next, we used DTT, a reducing sulfhydryl modifier, in the
perfusion fluid to see if it could mediate the inhibition of cardiac
function induced by NaHS. In addition to the fact that LV 6dp/
dtmax and DLVP did not change during perfusion with 100 mmol/
L DTT for 5 min as compared with controls (P.0.05, Fig. 1C), we
found that continuous perfusion of K-H solution with 100 mmol/L
NaHS for 10 min in the presence of DTT obviously decreased the
LV 6dp/dtmax and DLVP, compared to DTT perfusion without
NaHS treatment (P,0.01, Fig. 1C).
The effect of nifedipine on cardiac function in isolated
perfused rat hearts treated by NaHS
Compared with controls, the LV 6dp/dtmax and DLVP
decreased when perfused with the K-H solution consisting of
nifedipine at a dosage of 10 mmol/L for 5 min (P,0.05, Fig. 1D
and E). However, after continuous perfusion with the K-H
solution for 10 min, the ventricular 6dp/dtmax and DLVP
increased significantly as compared to those with K-H solution
consisting of nifedipine (P,0.01, Fig. 1E). Furthermore, the data
showed that continuous perfusion with NaHS at a dosage of
100 mmol/L following nifedipine perfusion could increase the
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PLoS ONE | www.plosone.org 3 May 2012 | Volume 7 | Issue 5 | e37073Figure 1. NaHS and sulfhydryl modifiers impacted NaHS-induced cardiac function. A: NaHS (100 mmol/L) depressed LV 6 dp/dtmax and
DLVP significantly as compared with the control.
**P,0.01 vs. control. B: NaHS (100 mmol/L) could not change LV 6 dp/dtmax and DLVP in the
presence of DM perfusion.
*P,0.05 vs. control,
#P,0.05 vs. DM. C: NaHS (100 mmol/L) could depress LV 6 dp/dtmax and DLVP in the presence of DTT.
**P,0.01 vs. DTT group. D and E: There were no significant differences in the change in the ventricular 6dp/dtmax and DLVP between the perfusate
with and without NaHS following nifedipine perfusion (P.0.05). The gray line stands for the experiment protocol ‘‘K-H +Nifei+K-H’’, and the black line
stands for the experimental protocol ‘‘K-H +Nifei+NaHS’’.
**P,0.01 vs control group.
##P,0.01 vs. nifedipine group.
doi:10.1371/journal.pone.0037073.g001
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no significant differences in the change in the ventricular 6dp/
dtmax and DLVP between the perfusate with and without NaHS
following nifedipine perfusion (P.0.05, Fig. 1D and 1E). Those
results suggested that pretreatment with nifedipine to inhibit L-
Ca
2+ channel could block the negative inotropic effect of NaHS.
Characteristics of the L-type calcium channel current in
rat ventricular cardiomyocytes
The L-type calcium currents were activated by a series of
depolarizing pulses from 250 mV to +70 mV at 10 mV
increments. This inward current could be almost completely
inhibited (95%) by 10 mmol/L nifedipine, a specific L-type
calcium channel blocker, and could be increased markedly
(300%) by 1 mmol/L Bay K 8644. Fig. 2A, B, C and D show
the representative traces and the corresponding I–V curves. The
peak of the I–V curve of the I Ca, L was at membrane potentials of
0 mV under control conditions and bath application of 1 mmol/L
Bay K 8644.
Inhibitory effect of NaHS on I Ca, L in rat ventricular
cardiomyocytes
I Ca, L was elicited by pulses from a holding potential of
240 mV to 0 mV for 200 ms every 1 min using the whole-cell
patch clamp technique. Four increasing concentrations of NaHS
(100, 200, 500 and 1000 mmol/L) were successively applied to the
cell for 3 min duration of perfusion per concentration, and the
effects of NaHS on the I Ca, L were detected. Representative
current traces in ventricular cardiomyocytes are shown in Fig. 2E.
Application of increasing concentrations of NaHS (100, 200, 500
and 1000 mmol/L) significantly reduced the amplitude of the peak
of I Ca, L to 85.1164.33%, 79.54611.65%, 74.44616.29% and
62.85618.53% of the value in the control at the same time point,
respectively. The inhibition of I Ca, L preceded rapidly in the first
1 min, and during the washout period (5 min) I Ca, L could be
partially recovered. Thus, the effects of NaHS on I Ca, L were
reversible at least in part.
Concentration-dependent inhibitory effect of NaHS on I
Ca, L
As shown in Fig. 2F and H, the bath application of NaHS in
various concentrations also inhibited the peak amplitude of the
calcium current. The NaHS decreased the concentration-response
curves of I Ca, L evoked by a single pulse from 240 mV to 0 mV
for 200 ms in the rat ventricular cardiomyocytes. In comparison
with the control, the peak amplitude of calcium current was
decreased successively from 82.0963.55%, 72.9768.51%,
62.91610.25% to 52.7569.78% of the control values by NaHS
at concentrations from 100, 200, 500 through 1000 mmol/L,
respectively. Dose-response curves were fitted by the logistic
function: Y=(A1-A2)/[1+(x/x0)
p]+A2, and Kd of NaHS on I Ca, L
was 376.66621.78 mmol/L. Fig. 2F and H show the I–V curves
constructed in the absence or presence of NaHS by applying a
200 ms voltage pulse ranging from 240 mV to +70 mV, in
10 mV increments. In order to avoid the influence of different cell
sizes, the I Ca-L was divided by the membrane capacitance, an
index of cell surface area. From Fig. 2F and H, I Ca, L density was
decreased significantly in ventricular cardiomyocytes obtained
from NaHS perfused groups (22.4460.17 pA/pF,
22.9160.26 pA/pF, 23.3760.22 pA/pF and 23.8060.29 pA/
pF for 1000, 500, 200 and 100 mM NaHS perfused groups,
respectively) compared to those from the control
(24.6360.34 pA/pF, n=6, P,0.05). Application of NaHS
showed a concentration-dependent suppression on the peak of
the I–V curves without altering the reversal potential and the
voltage dependence of peak I Ca, L.
Effect of NaHS on the current kinetics of L-type calcium
channel activation and inactivation
After perfusion of the cardiomyocytes with 1000 mmol/L
NaHS, the steady-state activation curve of the L-type calcium
channel (Fig. 2H) showed that the half-maximal activation voltage
(V1/2) did not change (from 220.160.65 to 219.4560.76 mV,
P.0.05, n=8). The K values were 4.8560.47 and 5.2760.69 in
the control and NaHS treated groups (P.0.05), respectively,
without shifting in the activation curve. For the steady-state
activation curve, currents were elicited by applying a series of
200 ms of depolarizing pulses (range from 270 mV to +30 mV in
10 mV increments) from a holding potential of 270 mV, and the
activation curves were fitted by the Boltzmann equation: G Ca/G
Ca Max=1-{1+exp[-(Vm-V1/2)/k]}
21.
Meanwhile, the effects of NaHS on the steady-state inactivation
characteristics of the L-type calcium channel (Fig. 2I) in
ventricular cardiomyocytes were observed with a 200 ms test
pulse of 0 mV after various pre-pulses which lasted for 1 s each
(range: from 270 mV to +30 mV; in 10 mV increments) to a
holding potential of 270 mV. The inactivation curves were
calculated using the Boltzmann equation: I Ca/I Ca max={1+exp
[(Vm-V1/2)/k]}
21. However, there was no significant difference in
the inactivation characteristics of the L-type calcium channel
between those of the NaHS perfused and of the control groups.
V1/2 values were 225.3860.68 and 225.8460.59 mV in the
control and the NaHS-treated groups (P.0.05, n=8), respective-
ly. The K values were 5.8860.25 and 6.0360.37 in the control
and NaHS perfused groups, respectively. There was no significant
shift in the steady state inactivation curve of I Ca, L.
The kinetics of recovery of I Ca, L from the inactivation curves
were tested with a double-pulse protocol: a 200 ms of conditioning
pulse to 0 mV followed by a 200 ms of test pulse to 0 mV from the
holding potential of 270 mV with increasing intervals to 500 ms
in increments of 20 ms. The recovery curve could be fitted by the
exponential equation: I Ca/I Ca max=12exp (2t/t). There was a
significant extension of I Ca, L recovery from inactivation, since the
time constant (t value) changed from 70.5664.43 to
162.86627.75 ms in the control and the NaHS (1000 mmol/L)-
treated groups, respectively (P,0.01, n=8) (Fig. 2J). The time
course of the recovery from the inactivation of I Ca, L was much
slower in the presence of NaHS. The effect of NaHS induced a
shift in the kinetics of recovery of I Ca, L from inactivation; and the
I/I max values of the NaHS perfused group significantly decreased
in comparison with that of the control, as the interval of pulses
increased stepwise from 20 to 200 ms in 20 ms increments.
Effects of sulfhydryl-modifying reagents (DM and DTT) on
cardiomyocyte L-type Ca
2+ channels
Fig. S1A shows the electrophysiological effects of 100 mmol/L
DM on ICa, L in a control cardiomyocyte group (curve 1)
compared with the 100 mmol/L DM-treated group (curve 2). The
peak I Ca, L elicited by test pulses from 240 to 0 mV was plotted
over a recording time course of a total of 14 min. In the DM-
treated (8 min) group, the peak I Ca, L markedly decreased by
48.6765.05% (n=6, P,0.05) compared with the control group. A
rapid depression took place at the beginning of the 5 min of
extracellular application of 100 mmol/L DM, while the steady
inhibitory effect of DM on I Ca, L developed from 7 min after the
drug perfusion.
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PLoS ONE | www.plosone.org 5 May 2012 | Volume 7 | Issue 5 | e37073Pooled data of the DTT-treated group and the controls are
shown in Fig. S1B. It was found that either 1 mmol/L or 5 mmol/
L DTT elicited almost no significant decrease in peak I Ca, L.
However, application of either 1 mmol/L or 5 mmol/L DTT had
a very slow and slightly decreasing effect on I Ca, L in a time-
dependent manner when the perfusion time was longer than
6 min.
Figure 2. Representative L-type calcium current (I Ca, L) in rat ventricular cardiomyocytes (A, B, C and D); NaHS inhibits the peak of I
Ca, L, and a gradual augmented concentration response relationship of NaHS-induced inhibition on I Ca, L (E); NaHS inhibited I Ca, L (F
and H); and effect of NaHS on the kinetics of I Ca, L activation and inactivation (I, G and K). A: Typical traces of whole-cell superimposed I
Ca, L.B :ICa, L was enlarged by 1 mmol/L Bay K 8644. C: I Ca, L was completely inhibited by 10 mmol/L nifedipine. D: Nifedipine could almost completely
inhibit (95%) the inward current, and Bay K 8644 could increase the inward current markedly (300%). E: Application of increasing concentrations of
NaHS (100, 200, 500 and 1000 mmol/L) significantly reduced the amplitude of the peak of I Ca, L, respectively, as shown in the figure labeled as b, c, d,
and e, respectively (‘‘a’’ stands for the beginning). The inhibition of I Ca, L preceded rapidly in the first 1 min, and during the washout period (5 min) I
Ca, L could be partially recovered (n=6 for each group). *P,0.05 vs. control. F: The inhibitory effects of NaHS on the peak of I Ca, L. Statistically
significant decreases in currents were apparent in four separate concentrations of NaHS (100, 200, 500 and 1000 mmol/L)-treated cells. G: The mean
current density-voltage for I Ca, L in rat left ventricular cardiomyocytes decreased significantly by four separate concentrations of NaHS (100, 200, 500
and 1000 mmol/L). H: 1000 mmol/L NaHS did not change the steady-state activation curve of the L-type calcium channel. I: 1000 mmol/L NaHS did not
change the steady-state inactivation curves of the L-type calcium channel. J: NaHS induced a shift in the kinetics of recovery of I Ca, L from inactivation;
and the I/I max values of the NaHS-perfused group significantly decreased in comparison with those of the control.
doi:10.1371/journal.pone.0037073.g002
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the inhibition of DM on peak I Ca, L could be abolished completely
by bath application of DTT. As shown in Fig. S1C, after
application of DM for 8 min, the peak Ca
2+ current decreased to
the lowest value; however, when 5 mmol/L DTT was applied, the
peak Ca
2+ current gradually increased. The mean peak amplitude
of calcium current obtained from perfusion with 5 mmol/L DTT
for 5 min increased from 67.1264.86% to 83.9164.92% of
baseline (n=6, P,0.01). Thus, it seems that the DTT has a
dissociating effect on the decrease in the L-type calcium currents
induced by DM.
Sulfhydryl modifiers impact NaHS-induced inhibition of
L-type calcium currents in cardiomyocytes
To examine if the NaHS-induced inhibitory effect on cardiac
function in isolated perfused rat hearts depends on protein
sulfhydryl groups, we used DM, an oxidizing sulfhydryl modifying
substance, and DTT, a reducing sulfhydryl modifying regent, in
this part of the experiment. Fig. 3A and Fig. 3B show the effect of
NaHS on the peak I Ca, L of L-type calcium channels of
cardiomyocytes pre-treated with DM and DTT, respectively. We
found that a significant decrease in peak amplitude of I Ca, L could
be reduced by pre-incubation with 100 mmol/L DM for 10 min,
and the decrease in peak amplitude of I Ca, L in cardiomyocytes
pre-treated by DM was basically constant and time-independent
from the beginning through the final time point of 1 mmol/L
NaHS perfusion period (beginning time point: 45.3864.01%, end
time point: 45.4365.04%, n=6, P.0.05), respectively, compared
with controls. The above data suggested that the state favoring
formation of protein disulfide bonds of cysteines blocked DM- or
H2S donor (NaHS)-induced inhibition of L-type calcium currents.
Furthermore, we found that the reduction of sulfhydryl with
DTT did not change the peak I Ca L, since the peak I Ca, L of
cardiomyocytes pre-treated with 1 mmol/L DTT for 10 min was
9761.24% of the controls (P.0.05). Removal of DTT by washing
with a 1 mmol/L NaHS-containing solution resulted to a
significant decrease in peak I Ca, L up to 65.366.06% of the
control values (n=6, P,0.05).
Fig. 3C showed that the NaHS induced a decrease in the peak I
Ca, L, and this decrease may be promptly reversed by DTT. The
peak of I Ca, L was 9761.44%, 58.5864.86% and 106.4464.92%
of the control, respectively, from the beginning until the end time
points of perfusion with 1 mmol/L NaHS, as well as during the
period of washing with 5 mmol/L DTT. Thus, the decrease in
peak I Ca, L induced by NaHS depended on the state of the free
sulfhydryl group. That is, NaHS affected L- type calcium channels
with the free sulfhydryl group but not with the disulfide bonded
cysteines on the L-type calcium channels.
Effects of NaHS on the free sulfhydryl groups of L-type
calcium channel in H9C2 cells
To demonstrate if H2S targeted sulfhydryl groups in the L-type
calcium channels in rat cardiomyocytes, we detected the ratio of L-
type calcium channel containing free sulfhydryl groups to total
protien of L-type calcium channel in H9C2 cells incubated with
100 mmol/L NaHS by using Western blot. In the NaHS-treated
group and the DM-treated group, the ratio of L-type calcium
channel containing free sulfhydryl groups to total protein L-type
calcium channel in H9C2 cells decreased obviously, compared
with that of the control group (P,0.01, Fig. 4 and 5). In the
NaHS+DTT treated group, however, the decreased ratio of L-
type calcium channel containing free sulfhydryl groups to total L-
type calcium channel protein in H9C2 cells was significantly
reversed, compared with that of the NaHS group (P,0.01, Fig. 4
and 5A). Additionally, compared with that of NaHS group, the
decraesed ratio of L-type calcium channel containing free
sulfhydryl groups to total L-type calcium channel protein in
H9C2 cells was also significantly reversed in GSH+NaHS group
(P,0.01, Figure 5B).
Discussion
The results showed that the H2S donor inhibited the I Ca, L in
cardiomyocytes, which is accordant to the previous results [6]. It
was reported that H2S might directly inhibit voltage-gated Ca
2+
channels in vascular smooth muscle by Zhao et al. in 2002 [14],
and it was also demonstrated that H2S was a novel inhibitor of L-
type calcium channels in cardiomyocytes through electrophysio-
logical measurements by Sun, et al. in 2009 [6]. Then, in 2011 Xu
et al. found that the L-type Ca
2+ channel agonist Bay K8644 could
prevent from the electrophysiological effects of H2S by using a
standard intracellular microelectrode technique [15]. The above-
mentioned results suggested that H2S could serve as an inhibitor of
L-type calcium channels and the reduction in calcium influx might
contribute to the functional effects of H2S [15]. DTT, a reductant
which transforms disulfide bridges into sulfhydryl groups in
cysteine-containing proteins, could markedly reverse the H2S
donor-induced inhibition of I Ca, L in cardiomyocytes. However, in
the presence of DM, an oxidant which transforms sulfhydryl
groups into disulfide bridges, NaHS could not alter cardiac
function and L-type calcium currents. Furthermore, we found that
after we treated the isolated rat heart or the cardiomycytes with
DTT, NaHS could markedly alter cardiac function in isolated
perfused heart and L-type calcium currents in the cardiomyocytes.
Thus, the results suggest that the decrease in peak I Ca, L induced
by NaHS depend on the state of free sulfhydryl group. NaHS can
affect L-type calcium channels with the sulfhydryl group, but it
cannot affect those with the disulfide bonded cysteine groups.
H2S is determined to be a gasotransmitter alongside with NO
and CO since it is a colorless, water-soluble and lipid-soluble gas of
small size and can be endogenously generated and regulated by
specific enzymes. It has broad physiological effects, but its relaxing
effect on the cardiovascular system is unique [16]. Our in vitro
study demonstrated that H2S can generate negative inotropic
effects on the isolated rat heart. For example, NaHS (10
26–
10
23 mol/L) could inhibit the ventricular contractile function in a
concentration-dependent manner, and NaHS of 10
23 mol/L
inhibited the coronary perfusive flow (CPF) and altered the left
ventricular pressure. Administration of NaHS to the rat heart
induced a transient negative cardiac inotropic effect and a
decrease in central venous pressure [17]. Consistent with the
results mentioned above, the present study confirmed that
perfusion of NaHS at a 100 mmol/L concentration significantly
decreased LV 6dp/dtmax and DLVP without changing heart rate
and CPF.
In accordance with the inhibition of ventricular contractile
function by the administration of NaHS, NaHS also inhibited I Ca,
L in rat cardiomyocytes in a concentration-dependent manner, but
without changing the channel dynamic characteristics (i.e., shift in
I–V relationship, activation and inactivation curves). The dynamic
characteristics of resting, activation and inactivation states of L-
type calcium channels could not be changed by H2S while the
recovery curve was inhibited, suggesting that H2S could quickly
occupy but then slowly dissociate from the L-type calcium
channels. The entry of Ca
2+ via the L-type calcium channels
would trigger the opening of the calcium-releasing channels
located in the calcium stores of the SR, and the increase in
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2+ concentration would induce the contraction of
cardiomyocytes. It has been reported [6] that H2S does not inhibit
the caffeine-induced increase in intracellular Ca
2+ concentration
([Ca
2+]i). We considered that H2S induced a local decrease in
[Ca
2+]i by blocking the L-type calcium channels but not by the
calcium-releasing channels of SR, and the decrease in [Ca
2+]i
would lead to the attenuated contraction of cardiomyocytes. Our
in vivo experiment gave the evidence that nifedipine pre-perfusion
could inhibit the negative cardiac inotropic effect exerted by H2S.
This result confirmed that the inhibition of ventricular contractile
Figure 3. Effects of H2S donor on I L, Ca modified by DM and DTT. A: DM significantly reduced the peak amplitude of I Ca, L in cardiomyocytes,
and the decrease by pre-treated with DM was basically constant and time-independent from the beginning through the final time point of 1 mmol/L
NaHS perfusion period. B: DTT did not change the peak I Ca L, while removal of DTT by washing out with a 1 mmol/L NaHS-containing solution could
decrease the peak I Ca, L significantly. C: NaHS induced a decrease in the peak I Ca, L, and this decrease promptly reversed by DTT.
doi:10.1371/journal.pone.0037073.g003
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calcium channels.
The substituted-cysteine accessibility method (SCAM) was
widely used to elucidate the functions of ion channels [18]. The
oxidation states of the sulfhydryl groups of the cysteine-containing
peptides and proteins are critical to stabilization of its structure
and function, and a special sulfhydryl modifier can localize
functional regions of the molecule. Sulfhydryl reagents are crucial
in SCAM. DTT is an effective sulfhydryl reductant that can
reduce disulfide bonds regardless of inter-chain or intra-chain
linkages [19]. DM is a commonly used sulfhydryl oxidizer since it
can promote formation of a disulfide bridge between two cysteine
residues when they are adjacent in the three-dimensional structure
of a protein [20]. In the present study we found that the L-type Ca
currents were decreased by 1 mmol/L DM, and the decrease
could be reversed by 5 mmol/L DTT, while either 1 mmol/L or
5 mmol/L DTT had no direct effect on I Ca, L. These results
suggest that the sulfhydryl groups on the L-type Ca
2+ channels are
important gate sites that can be directly modified by sulfhydryl
reagents. L-type calcium channel on myocardiocytic membrane
consists of a pore-forming a1c subunit and regulatory a2, d and b
subunits [21]. The a1c subunit which determines the basic
electrophysiological properties and effect as a voltage sensor and
receptor for antagonists/agonists has free sulfhydryl groups [22],
while disulfide bonds are present between the a2 and d subunits
[23]. DM provides an oxidative environment which can form a
disulfide bridge to stabilize the three-dimensional structure of the
protein. Therefore, it can be proposed that the formation of
disulfide bonds in the a1 subunit is the site affected by DTT.
Studies on N-ethylmaleimide (NEM), chloramine-T (CL-T), 2, 2¢-
dithiodipyridine (DTDP) and 2, 2¢-dithio-bis-5-nitropyridine
(DTBNP) also showed a diminished effect on I Ca, L. Other
results also indicated sulfhydryl reagents could directly act on the
ion channel, since the effect was not due to either cAMP
production or G-protein-coupled regulation of L-type Ca
2+
channels [12].
The present results confirmed that I Ca, L in the rat heart was
inhibited by H2S, and the thiol oxidant DM was observed to cause
a decrease in I Ca, L; and with pre-exposure to DM followed by
perfusion with H2S, the Ca
2+ current did not change compared
with the control value. DTT had no direct effect on I Ca, L,
although it could reverse the inhibition of I Ca, L by NaHS. Since
free sulfhydryl groups on the L-type Ca
2+ channels are the gate
sites, and they could be directly modified by hydrosulfuryl
reagents, H2S would have no targeting site since DM would have
already changed the oxidation state of the sulfhydryl groups of the
L-type Ca
2+ channels and formed a disulfide bridge between
adjacent cysteine residues in the three-dimensional structure. If
H2S targets on the crucial free-sulfhydryl groups on the Ca
2+
channel and inhibits the L-type calcium current, the inter-chain
disulfide bond linkages would be rapidly reduced by DTT, and
therefore the inhibition would be reversed. Thus, H2S appears to
function by activating a thiol oxidation mechanism that inhibits L-
type Ca
2+ channels.
To further demonstrate if H2S targeted the sulfhydryl groups in
the L-type calcium channels in rat cardiomyocytes, we measured
the ratio of L-type calcium channel containing free sulfhydryl
groups to total L-type calcium channel protein in H9C2 cells
incubated with H2S donor by Western blot. After treatment with
H2S donor, the ratio of L-type calcium channel containing free
sulfhydryl groups to total L-type calcium channel protein in H9C2
cells decreased obviously. However, the decreased ratio of L-type
Figure 4. Effects of NaHS on the free sulfhydryl groups of L-type calcium channel in H9C2 cells, and a schematic picture showing L-
type calcium channel and the other protein molecules involved in myocardial contraction that might react with H2S with their
sulfhydryl groups. In the NaHS group, the L-type calcium channel containing free sulfhydryl groups/total protein of L-type calcium channel ratio in
H9C2 cells decreased obviously, compared with that of the control group.
**P,0.01 vs control group.
doi:10.1371/journal.pone.0037073.g004
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calcium channel protein in H9C2 cells was significantly reversed
by a thiol reductant DTT. Additionally, it was also reversed by
another thiol reductant GSH, suggesting that H2S could target the
sulfhydryl group, decreasing the reduced thiol of L-Ca
2+ channel
in H9C2 cells, which could be reversed by thiol reductants.
We believe that the sulfhydryl groups on the cysteine-containing
proteins may play an important mechanistic role in the biological
effects of H2S on the cardiovascular system. Like L-type calcium
channels, the sulfhydryl groups of ATP-sensitive potassium
channels (KATP channels) also are the channel gate sites, and the
vasodilating effect ascribed to H2S to open KATP channels has
Figure 5. Effects of NaHS and sulfhydryl modifiers on the free sulfhydryl groups of L-type calcium channel in H9C2 cells. A: In NaHS
and DM group, the L-type calcium channel containing free sulfhydryl groups/total protein of L-type calcium channel ratio in H9C2 cells reduced
obviously, compared with that of the control group.
**P,0.01 vs control group. In the NaHS+DTT group, the L-type calcium channel containing free
sulfhydryl groups/total protein of L-type calcium channel ratio in H9C2 cells was reversed significantly, compared with that of the NaHS group.
##P,0.01 vs NaHS group. B: In NaHS group, the L-type calcium channel containing free sulfhydryl groups/total protein of L-type calcium channel
ratio in H9C2 cells reduced obviously, compared with that of the control group.
**P,0.01 vs control group. Compared with that of NaHS group, the L-
type calcium channel containing free sulfhydryl groups/total protein of L-type calcium channel ratio in NaHS+GSH group was reversed significantly.
mmP,0.01 vs NaHS group.
doi:10.1371/journal.pone.0037073.g005
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inhibitor to suppress the proliferation of vascular smooth muscle
cells (VSMCs) through the mitogen-activated protein kinase
(MAPK) pathway [24]. Previous research found that the
MAPK/extracellular-signal-regulated kinase kinase 1, an up-
stream activator of the stress-activated protein kinase/c-Jun N-
terminal kinase pathway, is directly inhibited by cysteine
modification. Further studies are needed to reveal details of the
substantial role for thiol modification of specific protein targets
involved in the H2S-mediated biological effects.
Supporting Information
Figure S1 L-type Ca
2+ current was affected by extracel-
lularly applied sulfhydryl modifying reagents. A: In the
DM-treated group. The peak I Ca, L markedly decreased,
compared with the control group. A rapid depression took place
at the beginning of the 5 min of extracellular application of
100 mmol/L DM, while the steady inhibitory effect of DM on I Ca,
L developed from 7 min after the drug perfusion. B: DTT elicited
almost no significant decrease in peak I Ca, L. However,
application of DTT had a very slow and slightly decreasing effect
on I Ca, L in a time-dependent manner when the perfusion time
was longer than 6 min. C: DTT almost completely reversed the
inhibition of DM on peak I Ca, L.
(TIF)
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